Oxymetazoline 0.1% Nasal Drop Franchise in Ahmedabad

Nasal Decongestant Therapy Supplier in Mumbai

Oxyniff Nasal Drop Distributor in Delhi

Rhinitis & Sinusitis Nasal Drop Franchise Opportunity in Bangalore

ENT Therapy Nasal Drop Stockist in Hyderabad
Oxymetazoline 0.1% Export & Manufacturing in Chandigarh

Home/Products /oxymetazoline-0-1-w-v-nasal-drop

About the Product

Description


Oxyniff Nasal Drop contains Oxymetazoline 0.1% w/v, a nasal decongestant indicated for the relief of nasal congestion associated with allergic rhinitis, sinusitis, common cold, and other upper respiratory conditions. It helps in reducing nasal swelling and improving airflow for easier breathing.

Oxymetazoline works by stimulating alpha-adrenergic receptors in nasal mucosa, causing vasoconstriction of blood vessels and decreasing congestion. Its nasal drop formulation ensures rapid onset and targeted action.

For distributors and healthcare suppliers, Oxyniff Nasal Drop is a high-demand ENT therapy product, commonly used in hospitals, clinics, and general practice for both adults and pediatric patients. The prevalence of nasal congestion and rhinitis ensures continuous demand throughout the year.

Adding Oxyniff Nasal Drop to your nasal care and ENT therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven efficacy, fast-acting formulation, and prescriber trust make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include mild burning, stinging, dryness, or irritation of the nasal mucosa. Rare but serious side effects include rebound congestion if used for prolonged periods, increased blood pressure, or palpitations. Patients should consult a doctor if severe or persistent symptoms occur.

Oxyniff Nasal Drop is indicated for the temporary relief of nasal congestion due to common cold, allergic rhinitis, sinusitis, or other upper respiratory tract conditions, as prescribed by a healthcare professional.

Oxyniff Nasal Drop should be used exactly as directed and not for more than 3–5 consecutive days to avoid rebound congestion. Patients with high blood pressure, heart disease, or thyroid disorders should consult their doctor before use. Avoid contact with eyes.

Store Oxyniff Nasal Drop in a cool, dry place away from direct sunlight. Keep out of reach of children and ensure the dropper bottle is tightly closed. Do not use beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Oxymetazoline 0.1% w/v Nasal Drop in the PCD pharma franchise market?

Oxymetazoline 0.1% w/v Nasal Drop has strong demand in the ENT care, respiratory care, allergy management, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on respiratory and ENT portfolios.

Why should medical distributors include Oxymetazoline 0.1% w/v Nasal Drop in their product range?

Medical distributors and agencies can benefit from consistent demand for nasal congestion relief products under medical guidance. Oxymetazoline 0.1% w/v is a topical nasal decongestant that helps reduce swelling in the nasal passages Commonly used for the temporary relief of nasal congestion associated with the common cold, sinusitis, allergic rhinitis, and other upper respiratory conditions as advised by healthcare professionals Helps improve airflow through the nasal passages and provides symptomatic relief from blocked nose Nasal drop formulation allows targeted local action and convenient administration Frequently utilized in ENT clinics, general practice, hospitals, and retail healthcare settings Widely recommended by ENT specialists, pediatricians, and general physicians This strengthens a comprehensive ENT and respiratory care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Oxymetazoline 0.1% w/v Nasal Drop with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong seasonal and year-round demand, repeat purchases, broad market acceptance, reliable supply chain support, and attractive margins in the ENT and respiratory care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.